12.94USD-0.92%Mkt Cap: 185.91M USDP/E: —Last update: 2026-06-01
Korro Bio, Inc., a biopharmaceutical company, engages in the discovering, developing, and commercializing of genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases in the United St…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap185.91M USD
Enterprise Value122.32M USD
Revenue (TTM)3.84M USD
Gross Profit-45.40M USD
Net Income (TTM)-117.26M USD
Revenue/Share0.3860 USD
Last Price12.94 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees49
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-2.66
PEG—
EV/EBITDA-1.54
EV/Revenue31.84
P/S50.34
P/B1.62
EPS (TTM)-11.68
EPS (Forward)-5.04
52W Range
5.20415% of range55.89
52W High55.89 USD
52W Low5.204 USD
Profitability
Gross Margin0.00%
Oper. Margin-2154.03%
EBITDA Margin0.00%
Profit Margin-1834.48%
ROE-227.96%
ROA-103.31%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-78.56M USD
CapEx (TTM)518.00K USD
FCF Margin-1016.09%
FCF Yield-21.00%
Net Debt-71.08M USD
Net Debt/EBITDA0.90
Balance Sheet
Debt/Equity0.85
Current Ratio8.13
Quick Ratio7.71
Book Value/Sh8.295 USD
Cash/Share7.902 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:50
Split DateNov 6, 2023
Analyst Consensus
Rating1.4 (Strong Buy)
Target (Mean)19.89 USD
Target Range8.000 USD – 30.00 USD
# Analysts9
Ownership
Shares Out.14.42M
Float9.36M
Insiders0.57%
Institutions100.62%
Short Interest
Short Ratio13.6d
Short % Float9.30%
Short % Out.8.28%
Shares Short1.19M
Short (prev mo.)1.09M
Technical
SMA 5012.31 (+5.1%)
SMA 20018.38 (-29.6%)
Beta2.23
S&P 52W Chg27.94%
Avg Vol (30d)105.44K
Avg Vol (10d)157.33K
Technical Indicators
RSI (14)57.2
MACD-0.0142
MACD Signal-0.3179
MACD Hist.+0.3037
BB Upper14.47 USD
BB Middle11.82 USD
BB Lower9.176 USD
BB Width44.79%
ATR (14)0.9558 USD
Vol Ratio (20d)0.65x